| Methods | Trial design: randomised clinical trial. Randomisation and allocation: no details on allocation concealment. Blinding: no details on blinding. Number of participants: 45 women randomised, 24 in treatment, 21 in control. | |
| Participants | Inclusion: history of primary dysmenorrhoea beginning within 2 years of menarche; regular cycle; moderate, severe or disabling dysmenorrhoea in each cycle, beginning day before or at onset of flow. Exclusion: excluded if any pelvic abnormality, endometriosis, use of birth control pills or IUD, or contraindications to spinal manipulation. Women also asked not to use analgesics during study and to abstain from exercise or intercourse 24 hr prior to treatment. Age: 20‐40 (mean 30.3) years. Source: recruited from local community by advertisements or referrals from chiropractors or gynaecologists. Location: chiropractic clinic in Chicago, USA. | |
| Interventions | Treatment: high velocity low amplitude manipulation to clinically relevant vertebral and sacroiliac joints. Control: sham manipulation to midline base of sacrum. Duration: one treatment only. | |
| Outcomes | VAS for abdominal pain. VAS for back pain. MDQ for menstrual distress. All scales assessed 15 min before and 60 min after treatment. Blood samples for KD PGF2α. | |
| Notes | Outcome measurement rather limited temporally. No information on whether effects lasted longer than 1 hr post‐treatment. | |
| Risk of bias | ||
| Bias | Authors' judgement | Support for judgement |
| Adequate sequence generation? | Unclear risk | No details |
| Allocation concealment? | Unclear risk | No details |
| Blinding? All outcomes | High risk | No details of blinding |
| Incomplete outcome data addressed? All outcomes | Low risk | All participants accounted for |
| Free of selective reporting? | High risk | Outcome measurement rather limited temporally. No info on whether effects lasted longer than 1 hr post‐treatment |